Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200

Cancer immunotherapy strategies are based on the utilization of immune checkpoint inhibitors to instigate an antitumor immune response. The efficacy of immune checkpoint blockade, directed at adaptive immune checkpoints, has been demonstrated in select cancer types. However, only a limited subset of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Sun Young, Han, Minjoo, Ryu, Gyoungah, Shin, Seong-Ah, Lee, Jun Hyuck, Lee, Chang Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606340/
https://www.ncbi.nlm.nih.gov/pubmed/37894750
http://dx.doi.org/10.3390/ijms242015072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606340/
https://www.ncbi.nlm.nih.gov/pubmed/37894750
http://dx.doi.org/10.3390/ijms242015072

Ejemplares similares